Laboratory handling of Helicobacter pylori critically influences the results of in-vitro metronidazole resistance determination
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (4) , 315-321
- https://doi.org/10.1111/j.1198-743x.2004.00779.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rateEuropean Journal of Gastroenterology & Hepatology, 1999
- Pretreatment Antibiotic Resistance inHelicobacter pyloriInfection: Results of Three Randomized Controlled StudiesHelicobacter, 1999
- The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcerAlimentary Pharmacology & Therapeutics, 1999
- Antibiotic resistance problems with Helicobacter pyloriInternational Journal of Antimicrobial Agents, 1999
- The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapiesGastroenterology, 1999
- SHOULD WE ABANDON METRONIDAZOLE CONTAINING HELICOBACTER PYLORI TREATMENT REGIMENS? THE CLINICAL RELEVANCE OF METRONIDAZOLE RESISTANCEAmerican Journal of Gastroenterology, 1998
- Antibiotic resistance in Helicobacter pylori infection.British Medical Bulletin, 1998
- Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I StudyHelicobacter, 1996
- Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapyJournal of Gastroenterology and Hepatology, 1996
- Results of a multicentre European survey in 1991 of metronidazole resistance inHelicobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992